Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser(167) in endometrioid endometrial cancer

about

The biology of aging and lymphoma: a complex interplay.Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?

P2860

Q38500035-2B1046CD-2006-4D51-8CF6-8679FBF93572 Q51480749-2B562C9A-65A7-4F76-A6A3-D972F70E2774 Q54942423-8B207D64-751F-40F3-8DBB-7A9A4243CFA3

P2860

Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser(167) in endometrioid endometrial cancer

Item

http://www.wikidata.org/entity/Q35713164

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Relation between outcomes and ...... ndometrioid endometrial cancer

@ast

Relation between outcomes and ...... ndometrioid endometrial cancer

@en

type

Item

label

Relation between outcomes and ...... ndometrioid endometrial cancer

@ast

Relation between outcomes and ...... ndometrioid endometrial cancer

@en

prefLabel

Relation between outcomes and ...... ndometrioid endometrial cancer

@ast

Relation between outcomes and ...... ndometrioid endometrial cancer

@en

P1476

Relation between outcomes and ...... ndometrioid endometrial cancer

@en

P2093

Akiko Shinagawa

http://www.w3.org/2001/XMLSchema#string

Eiichi Kato

http://www.w3.org/2001/XMLSchema#string

Makoto Orisaka

http://www.w3.org/2001/XMLSchema#string

Tetsuji Kurokawa

http://www.w3.org/2001/XMLSchema#string

Yoko Chino

http://www.w3.org/2001/XMLSchema#string

Yoshio Yoshida

http://www.w3.org/2001/XMLSchema#string

Yuko Fujita

http://www.w3.org/2001/XMLSchema#string

P2860

Hormonal therapy in advanced or recurrent endometrial cancer

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.

Resistance to chemotherapy and hormone therapy in endometrial cancer.

The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.

mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation.

p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.

S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.

Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients.

P304

1307-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12491

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265053730

http://www.w3.org/2001/XMLSchema#string

P698

25154549

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4462347

http://www.w3.org/2001/XMLSchema#string

Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser(167) in endometrioid endometrial cancer

about

P2860

P2860

Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser(167) in endometrioid endometrial cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932